Experience
Grünenthal GmbH
Actavis Elizabeth LLC et al.
Represented Grünenthal GmbH in multiple Hatch-Waxman suits involving analgesic drugs Nucynta® and Nucynta® ER; the district court enjoined the defendants from marketing generic versions until patent expiry.
Grünenthal GmbH v. Actavis Elizabeth LLC et al., 2:13-cv-04507, -06929, -07803; 2:14-cv-03941, -04617; 2:15-cv-06797, D.N.J., Judges Cecchi, Falk
The Hillman Group, Inc. v. KeyMe, LLC
The Hillman Group, Inc.
Bright Data Ltd. v. NetNut Ltd.
NetNut Ltd.
American Regent, Inc. v. Pharmacosmos Therapeutics Inc. et al.
American Regent, Inc.
Hawk Technology Systems, LLC v. Kirkland's Inc.
Kirkland's Inc.
Rondevoo Technologies, LLC v. RSIP Vision, Inc.
RSIP Vision, Inc.
Eureka Database Solutions, LLC v. Nexidia, Inc.
Nexidia, Inc.
Guntert & Zimmerman Const. Div., Inc. v. GOMACO Corporation
GOMACO Corporation
Koninklijke Philips NV and IP2IPO Innovations, Ltd. v. Boston Scientific Corp.
Koninklijke Philips NV and IP2IPO Innovations, Ltd.
Delta Faucet Company v. Globe Union Industrial Corp. et al.
Globe Union Industrial Corp.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.